Concert Pharmaceuticals Probability of Future Stock Price Finishing Over 8.37
| CNCEDelisted Stock | USD 8.37 0.01 0.12% |
Concert |
Concert Pharmaceuticals Target Price Odds to finish over 8.37
The tendency of Concert Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.37 | 90 days | 8.37 | about 17.22 |
Based on a normal probability distribution, the odds of Concert Pharmaceuticals to move above the current price in 90 days from now is about 17.22 (This Concert Pharmaceuticals probability density function shows the probability of Concert Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Concert Pharmaceuticals has a beta of -0.42 suggesting as returns on the benchmark increase, returns on holding Concert Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Concert Pharmaceuticals is likely to outperform the market. Additionally Concert Pharmaceuticals has an alpha of 0.9237, implying that it can generate a 0.92 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Concert Pharmaceuticals Price Density |
| Price |
Predictive Modules for Concert Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Concert Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Concert Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Concert Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Concert Pharmaceuticals is not an exception. The market had few large corrections towards the Concert Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Concert Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Concert Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.92 | |
β | Beta against Dow Jones | -0.42 | |
σ | Overall volatility | 1.65 | |
Ir | Information ratio | 0.16 |
Concert Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Concert Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Concert Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Concert Pharmaceuticals is not yet fully synchronised with the market data | |
| Concert Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 32.58 K. Net Loss for the year was (80.05 K) with loss before overhead, payroll, taxes, and interest of (54.98 M). | |
| Concert Pharmaceuticals currently holds about 154.57 M in cash with (55.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Concert Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Concert Stock often depends not only on the future outlook of the current and potential Concert Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Concert Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 34.4 M | |
| Cash And Short Term Investments | 143.1 M |
Concert Pharmaceuticals Technical Analysis
Concert Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Concert Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Concert Pharmaceuticals. In general, you should focus on analyzing Concert Stock price patterns and their correlations with different microeconomic environments and drivers.
Concert Pharmaceuticals Predictive Forecast Models
Concert Pharmaceuticals' time-series forecasting models is one of many Concert Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Concert Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Concert Pharmaceuticals
Checking the ongoing alerts about Concert Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Concert Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Concert Pharmaceuticals is not yet fully synchronised with the market data | |
| Concert Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 32.58 K. Net Loss for the year was (80.05 K) with loss before overhead, payroll, taxes, and interest of (54.98 M). | |
| Concert Pharmaceuticals currently holds about 154.57 M in cash with (55.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Concert Stock
If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |